Studies have also shown that NF-κB pathway inactivation is an effective treatment target for DCM [82,83], and NF-κB signaling pathway can also cooperate with AGEs and NOX signaling pathways to cause more severe oxidative damage [84,85]. This evidence concerns the gene NFKB1 and familial dilated cardiomyopathy.